Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.

Tobias SchlesingerBenedikt WeißbrichFlorian WedekinkQuirin NotzJohannes HerrmannManuel KroneMagdalena SitterBenedikt SchmidMarkus KredelJan StumpnerLars DölkenJörg WischhusenPeter KrankePatrick MeybohmChristopher Lotz

Published in: PloS one (2020)

COVID-19 induced ARDS is accompanied by a high viral load of SARS-CoV-2 in tracheal aspirates, which remained detectable in the majority throughout intensive care treatment. Remarkably, SARS-CoV-2 RNA was never detected in dialysate even in patients with RNAemia. Viral load or the buildup of neutralizing antibodies was not associated with 30-day survival or disease severity.

Keyphrases

sars cov
respiratory syndrome coronavirus
high glucose
acute respiratory distress syndrome
diabetic rats
mechanical ventilation
extracorporeal membrane oxygenation
coronavirus disease
drug induced
endothelial cells
computed tomography
peritoneal dialysis
pet ct
positron emission tomography
aedes aegypti